Sharjah's University Hospital Sharjah and Thumbay Hospital serve a significant patient population including Sharjah's large South Asian expatriate community, many of whom are at higher COVID risk due to older age, diabetes, or other comorbidities. Molnulee from Unnati Pharmax provides Sharjah pharmacies and private clinics with affordable Molnupiravir supply for high-risk COVID patients.
Sharjah's proximity to Dubai and its role as a more affordable residential hub for UAE-based workers creates specific demand for cost-effective medicines. Generic Molnulee at significantly reduced cost versus brand Lagevrio makes COVID antiviral treatment accessible to Sharjah's working-class and middle-income expatriate population who may face higher co-payments at hospital pharmacies.
Visit medshopy.com or WhatsApp +91 82650 41513 for UAE supply.
Sharjah's proximity to Dubai and its role as a more affordable residential hub for UAE-based workers creates specific demand for cost-effective medicines. Generic Molnulee at significantly reduced cost versus brand Lagevrio makes COVID antiviral treatment accessible to Sharjah's working-class and middle-income expatriate population who may face higher co-payments at hospital pharmacies.
Visit medshopy.com or WhatsApp +91 82650 41513 for UAE supply.
Can Molnupiravir be used in patients with chronic kidney disease — is dose adjustment needed?Based on available data, Molnupiravir does not require dose adjustment in patients with mild-to-moderate chronic kidney disease (CKD). Molnupiravir is metabolised to its active form primarily in the intestinal wall and tissues, and its elimination is through multiple pathways not predominantly dependent on renal excretion of the parent compound. For patients with severe renal impairment or end-stage kidney disease, data is more limited, and prescribing decisions should be made with a nephrologist or specialist experienced in managing medications in this population. CKD patients in the UAE are a significant population given the high prevalence of diabetes-driven nephropathy — making this a practically important clinical question for Sharjah clinicians.
